News | October 14, 2013

Voices Against Brain Cancer Comments on Preservation of Cognitive Function After Radiotherapy

October 14, 2013 — Voices Against Brain Cancer (VBAC), an organization dedicated to brain cancer research and advocacy, discussed a study that looked into the preservation of cognitive function for brain cancer patients after radiotherapy treatments.

According to an October 7 article published by Drug Discovery & Development magazine titled “Drug Preserves Cognitive Function After WBRT for Brain Cancer,” researchers at Emory’s Nell Hodgson Woodruff School of Nursing and the Winship Cancer Institute conducted a study that highlighted positive outcomes “in long-term cognitive function due to the use of the cognitive drug Memantine.” The findings could be used to help brain cancer patients who undergo whole-brain radiotherapy (WBRT). Although it has been proven to be a therapeutic survival tool in the treatment of adults with brain tumors, it does have lingering negative effects in the long-term brain function and performance of those who undergo this treatment.

In the study, 508 eligible adult WBRT patients received placebo or memantine within three days of starting WBRT and for 24 weeks in “graduated doses.” The participants were then given a series of cognitive function tests and also underwent neurologic exams, history and physical exams, performance status and brain magnetic resonance imaging (MRIs) and computer tomography (CT) scans.

Deborah Watkins Bruner, Ph.D., R.N., professor, Nell Hodgson Woodruff School of Nursing and associate director of cancer outcomes, Winship Cancer Institute at Emory, was content with the preliminary results, which showed better cognitive function over time for those who took memantine.

“We specifically saw a delay in the time of cognitive decline and reductions in the rates of memory loss, executive function and processing-speed declines,” said Watkins-Bruner.

Michael Klipper, chairman, VBAC, said this finding will provide hope to the brain cancer community.

“Even though this study is still in its preliminary trial and some questions about the drug’s effectiveness do remain, this is an extremely positive step towards preventing cognitive dysfunction and bettering the lives of brain cancer patients,” said Klipper.

For more information: www.voicesagainstbraincancer.org, www.dddmag.com

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init